Ally Bridge Group (Ny) LLC Top Holdings and 13F Report (2026) About Ally Bridge Group (Ny) LLCInvestment ActivityAlly Bridge Group (Ny) LLC has $123.81 million in total holdings as of March 31, 2026.Ally Bridge Group (Ny) LLC owns shares of 26 different stocks, but just 17 companies or ETFs make up 80% of its holdings.Approximately 50.15% of the portfolio was purchased this quarter.About 29.92% of the portfolio was sold this quarter.This quarter, Ally Bridge Group (Ny) LLC has purchased 16 new stocks and bought additional shares in 7 stocks.Ally Bridge Group (Ny) LLC sold shares of 5 stocks and completely divested from 2 stocks this quarter.Largest Holdings Soleno Therapeutics $13,392,000PRAXIS PRECISION MEDICINES I $10,571,054Minerva Neurosciences $9,974,388Ovid Therapeutics $6,256,979Compass Pathways $5,778,850 Largest New Holdings this Quarter 87650L103 - Tarsus Pharmaceuticals $5,672,259 Holding20454B104 - Compass Therapeutics $5,290,000 Holding23284F105 - CytomX Therapeutics $4,230,000 Holding46489V302 - PERSPECTIVE THERAPEUTICS INC $3,863,743 Holding022307102 - ALUMIS INC $3,678,107 Holding Largest Purchases this Quarter Soleno Therapeutics 231,971 shares (about $7.77M)Tarsus Pharmaceuticals 80,859 shares (about $5.67M)Compass Therapeutics 1,000,000 shares (about $5.29M)CytomX Therapeutics 900,000 shares (about $4.23M)PRAXIS PRECISION MEDICINES I 12,928 shares (about $4.17M) Largest Sales this Quarter Edgewise Therapeutics 284,000 shares (about $8.95M)Replimune Group 953,100 shares (about $7.29M)Inventiva 754,700 shares (about $4.19M)ABIVAX SA 36,288 shares (about $4.04M)Compass Pathways 55,000 shares (about $304.15K) Sector Allocation Over TimeMap of 500 Largest Holdings ofAlly Bridge Group (Ny) LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorSLNOSoleno Therapeutics$13,392,000$7,766,389 â–²138.1%400,00010.8%MedicalPRAXIS PRECISION MEDICINES I$10,571,054$4,165,272 â–²65.0%32,8108.5%COM NEWNERVMinerva Neurosciences$9,974,3880.0%1,655,5008.1%MedicalOVIDOvid Therapeutics$6,256,979$2,294,279 â–²57.9%2,818,4595.1%MedicalCMPSCompass Pathways$5,778,850$304,150 â–¼-5.0%1,045,0004.7%MedicalTARSTarsus Pharmaceuticals$5,672,259$5,672,259 â–²New Holding80,8594.6%MedicalSLDBSolid Biosciences$5,522,213$2,544,113 â–²85.4%766,9744.5%MedicalCMPXCompass Therapeutics$5,290,000$5,290,000 â–²New Holding1,000,0004.3%MedicalPROMIS NEUROSCIENCES INC$5,260,581$2,093,976 â–²66.1%414,2194.2%COM SHSEWTXEdgewise Therapeutics$5,071,500$8,946,000 â–¼-63.8%161,0004.1%MedicalQUREuniQure$4,905,000$1,635,000 â–²50.0%300,0004.0%MedicalEUPRAXIA PHARMACEUTICALS INC$4,781,115$1,900,355 â–²66.0%660,3753.9%COMCTMXCytomX Therapeutics$4,230,000$4,230,000 â–²New Holding900,0003.4%MedicalIVAInventiva$4,136,415$4,188,585 â–¼-50.3%745,3003.3%MedicalPERSPECTIVE THERAPEUTICS INC$3,863,743$3,863,743 â–²New Holding926,5573.1%COM NEWABIVAX SA$3,753,831$4,040,669 â–¼-51.8%33,7123.0%SPONSORED ADSALUMIS INC$3,678,107$3,678,107 â–²New Holding166,9593.0%COMURGNUrogen Pharma$3,634,190$3,634,190 â–²New Holding202,1242.9%MedicalCAPRCapricor Therapeutics$3,462,530$3,462,530 â–²New Holding113,8992.8%MedicalMAZE THERAPEUTICS INC$2,985,000$2,985,000 â–²New Holding100,0002.4%COMAADIAadi Bioscience$2,821,8900.0%817,9392.3%MedicalINHIBIKASE THERAPEUTICS INC$2,226,000$2,226,000 â–²New Holding1,325,0001.8%COM NEWREPLReplimune Group$1,888,785$7,291,215 â–¼-79.4%246,9001.5%MedicalAN2 THERAPEUTICS INC$1,799,997$1,799,997 â–²New Holding526,3151.5%COMRLMDRelmada Therapeutics$1,465,254$1,465,254 â–²New Holding210,5251.2%MedicalKARYOPHARM THERAPEUTICS INC$1,392,500$1,392,500 â–²New Holding250,0001.1%COM NEWATAIAtai Beckley$0$7,006,599 â–¼-100.0%00.0%MedicalTSHATaysha Gene Therapies$0$5,264,226 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
